Surgical Robots Market — By Component, By Application, By End Use — Global Forecast, 2024 to 2032

Surgical Robots Market Size

The global surgical robots market size was valued at USD 7.1 billion in 2023. The market is expected to reach from USD 8.1 billion in 2024 to USD 26.8 billion in 2032, growing at a CAGR of 16.2% during the forecast period. The market growth of surgical robots can be attributed to the increased reliance on surgical robots, escalation in the number of surgical procedures, expansion in healthcare expenditure, and a rise in chronic disease prevalence.
 

Moreover, the highly sophisticated robotic mechanisms are of utmost importance for different modern surgical techniques for challenging and deep anatomy sites. For instance, robotic surgery has become more commonplace in the U.S. and as of 2021, there were over 644,000 performed procedures which is estimated to increase to 1 million by 2028 according to statistics published by WebMD. Along this, the robotic technology has enabled surgeons to conduct intricate procedures within a controlled environment, an important factor in ensuring the best possible outcome for patients.
 

In addition, and most importantly, robotic systems in surgery have shown to lead to favorable clinical outcomes, including fewer complications, less hemorrhage, and better tissue altruism versus open surgeries. Because this kind of evidence keeps accumulating, more and more hospitals or doctors as well are adopting robotic systems for better patient care.
 

Surgical robots are the advanced medical devices with robotic arms and instruments attached to it. As these robots are used to perform surgical procedures, they are called as surgical robots. Surgical robots are fed with programs of surgical decision based on which they assist surgeons in performing minimally invasive surgeries.
 

Surgical Robots Market Trends

The advancement of technology has changed the field of surgical robotics and medical practices. These innovations have significantly empowered surgeons and enhanced surgical outcomes.
 

• Robotic arms are now extensively used in several medical fields, such as cardiothoracic, gynecological, neurosurgical, orthopedic, and even oncological surgery. The da Vinci surgical system is one of the most advanced robotic systems. It has a surgeon's console, a cart with 4 robotic arms to be positioned next to the patient, and a rigid endoscope equipped with a stereoscopic vision system. Surgeons insert a console and maneuver robotic arms in order to perform surgeries with utmost precision and control.
   
• The 3D vision system equipped on the da Vinci system magnifies the view of the surgical site. In addition, the robotic fenestration reduces shaking movements by the doctor. As a result, the system is able to augment the precision of surgery. The company's 2023 annual report estimates that in 2023, over 2.3 million procedures utilizing the da Vinci system were completed worldwide, which signifies an increase of over 22% from 2022. Some of the operations performed include prostatectomy, hysterectomy, coronary artery bypass and colectomy.
   
• In 2023, the FDA approved further application of da Vinci system for the purposes of thoracic surgical procedures. The clinical studies of 2022 suggest that inpatient stays and post-surgery procedures were decreased by 30% and 25% respectively when using the da Vinci system in contrast with standard surgery.
   
• Moreover, the implementation of recently developed morphologic cameras with the robotic sensor along with the 3D scanning functions has fully altered the perception of surgeons towards any given structure. This technology allows surgeons to perform the most delicate and challenging operations with accuracy, distinctness, and lesser cutout areas, which in turn increases the ease of use and provides significant boost to the market.
   

Surgical Robots Market Analysis

Based on component, the market is segmented into robot systems and instruments and accessories. The instruments and accessories segment held a dominant market share and was valued at USD 3.9 billion in 2021, USD 4.3 billion in 2022, and USD 4.8 in 2023, and it is projected to reach USD 18.9 by 2032.
 

• The increased acceptance of robotic surgery in urology, gynecology, orthopedics, and even general surgery is perpetually increasing the need for surgical instruments and accessories. As an illustration, data from the American Hospital Association shows that robotic-assisted procedures have risen by 22% within the period of 2021 to 2023 in the U.S. Such procedures primarily require vast amounts of staplers, sutures, and surgical graspers, which creates incessant sustenance in the market.
   
• Moreover, the use of articulating instruments, haptic feedback, and artificial intelligence for robotic surgery is improving its accuracy. The creation of energy devices, suturing devices, and micro-instruments provides more benefits and efficient results. These innovations increase the market demand for modern and advanced accessories and tools.
   
• Further, the robotic surgical instruments are either single-use or have capped usage cycle owing to rigid sterility and safety measures. These surgical instruments, along with accompanying tools, are substituted on a regular basis which guarantees continual revenue for the manufacturers.
   
• Along with the necessity of keeping infections in check, there is increasing requirement for disposable surgical accessories. For example, in 2023, revenue from surgical Instruments grew by 24%, which amounted to USD 4.1 billion according to Intuitive Surgical.
   

Based on application, the surgical robots market is categorized into orthopedic surgery, neurosurgery, general surgery, gynecology surgery, urologic surgery, and other applications. The general surgery segment holds the dominant position, accounted for USD 2.1 billion in 2023 and is expected to grow at 16.8% CAGR from 2024 to 2032.
 

• The high rate of obese population, cancers, metabolic diseases, and gastro disorder are promoting the growth of robotic-assisted general surgeries. According to a World Health Organization study, between 2021 and 2023, 39% of older people were found to be overweight or obese.
   
• The American Cancer Society published 1.9 million new cancer cases in 2022, as the International Diabetes Federation published that 537 million adults were diabetic in 2021. The increased adoption of robotic systems in bariatric surgery, colectomy, and hepatobiliary surgery is driven by the surgical systems' advanced accuracy.
   
• Further, the growth of robotic-assisted general surgeries is based on approvals and new guidelines given by the FDA and CE for robotic surgery devices and tools. In 2023, the Moment Surgical Anovo system received FDA clearance for robotic-assisted transvaginal gynecological surgeries. Like CMR's surgical robotic system, which was granted FDA clearance in 2022.
   
• Moreover, these technologies are being used by more hospitals and surgeons because of better reimbursement policies. Under Medicare's 2024 HOPPS final rule, payment rates were increased by 3.1% for outpatient robotic-assisted procedures.
   
• UnitedHealthcare extended coverage for knee replacements in 2023 to include assisted robotic procedures, which is estimated to cover around 45 million members. These above factors are anticipated to drive the segment growth.
   

Based on end-use, the surgical robots market is categorized into hospitals and ambulatory surgical centers. Hospitals segment is accounted for the largest market share of 72.2%, valued at USD 5.1 billion in 2023, and is anticipated to witness significant growth over the analysis timeframe, at a CAGR of 16.6%.
 

• Because of its ability to enhance precision and assist in complex medical procedures, more hospitals are starting to install robotic systems in their facilities. Surgical robots allow the precise and definitive mastery of dexterity, movement, and 3D visualization, further leading to more accurate minimally invasive surgeries, in turn fewer complications and better outcomes overall. For this reason, more hospitals already adopt robotic technology for better surgical results.
   
• Additionally, the high initial investment in robotic systems is offset by long-term cost savings for hospitals. According to article from the Journal of Clinical Medicine, robotic surgery reduced hospital stays by 37% and post-operative complications by 52% in 2022 when compared to conventional treatments.
   
• Readmission rates for robotically assisted procedures decreased by 28% in 2022, according to Medicare statistics. These demonstrated benefits make robotic systems important to hospitals looking to improve patient outcomes and cost efficiency.
   

North America surgical robots market size in 2023 was valued at USD 4.2 billion and is predicted to grow at a CAGR of 15.1% over the analysis timeframe.
 

• The healthcare costs in North America, especially in the U.S. and Canada, are remarkably high. In 2022, the U.S. healthcare expenditure reached USD 4.5 trillion, reflecting a 4.1% rise from the previous year. Hospitals in this region are actively buying robotic surgery systems, and during 2022-2023, Intuitive Surgical purchased 1,370 da Vinci systems in North America. The region's commitment to enhancing surgical technology is further demonstrated by the FDA's approval of 25 new robotic surgery systems between 2021 and 2023. Moreover, in 2023, the Canadian government allocated CAD 2 billion to upgrade surgical facilities throughout the provinces, which includes the implementation of robotic surgical systems.
   
• The escalating number of chronic conditions is driving the need for robotic-assisted surgery, which is helping to grow the market in the area. For instance, the Center for Chronic Disease Prevention revealed that in 2023, 60 percent of adults in the U.S. were affected with one or more chronic illnesses.
   
• Additionally, healthcare providers in the area are more concerned with enhancing patient health outcomes while decreasing the rate of hospital readmissions. Robotic surgery is one of the newest surgical approaches that can reduce the trauma of surgery and recovery time. This results in lower readmission rates, which translates into improved patient outcomes fosters satisfaction, and is a considerable motivator towards using robotic systems.
   

Germany is projected to grow remarkably in Europe surgical robots market and is expected to grow in the coming years.
 

• Germany’s healthcare system is one of the most advanced in Europe when it comes to technology and innovation. The growth in the use of robotic surgical systems is propelled by the existence of advanced hospitals, specialized surgical centers, and high investment in medical technology. Many hospitals are adopting robotic-assisted surgery to enhance accuracy, efficiency, and patient outcomes.
   
• In addition, the German government sponsors the development of healthcare technologies, including robotic surgery. Most robotic-assisted surgeries are covered by statutory health insurance (SHI) and private health insurers, leading to increased patient access. In 2023, the German Federal Ministry of Health earmarked USD 6.8 billion towards healthcare digitalization initiatives.
   
• The German Hospital Federation (DKG) reports that in 2023, 85% of university hospitals had at least one surgical robot system, up from 60% in 2021. The reimbursement model in place encourages investment in robotic systems, thereby promoting market growth.
   

Japan is experiencing high market growth in the Asia Pacific surgical robots market.
 

• In 2023, Japan performed robotic-assisted surgeries on more than 28% of patients aged above 65, which is the country’s fastest growing demographic. These surgeries include orthopedic, cardiovascular, and urological procedures. The Ministry of Health, Labour, and Welfare states that over 85,000 robotic-assisted surgeries were performed in Japan in 2022.
   
• The medicinal market is increasingly adapting to the use of robotic surgery as there is an almost global rise in the need for minimalistic surgeries which cause less damage to the body as well as pain and recovery time. Both, Intuitive Surgical and Medicaroid Corporation reported a boost in sales and new system approvals leading to a 22% nearly year over year increase in the sales of hocus surgical systems throughout Japan in 2023 and expansion of medicaroid controlled systems was made legally available in 2024.
   
• Furthermore, Japanese patients showcase the highest levels of preparedness to spend on advanced medical procedures, especially regarding robotic-assisted surgeries that can be found throughout the world. The increasing international medical tourism sector further fosters international patients bidding for advanced robotic procedures to Japan, triggering a need for surgical robots in hospitals.
   

Surgical Robots Market Share

The market is highly consolidated in nature, with the top key players, namely Intuitive Surgical, Stryker Corporation, Medtronic plc, and ACCURAY Inc. account for 85% of the market share. This high share is owing to their cutting edge robotic platforms, robust distribution networks, and innovation led business models. The firms have successfully entered the robotic-assisted orthopedics and neurosurgery segments and are doing well with minimally invasive surgeries.
 

Furthermore, local companies such as Kawasaki Heavy Industries and Medicaroid have also made progress by providing affordable robotic systems that meet the needs of the expanding elderly population and the rising volume of minimally invasive surgeries. Japan's continual efforts to maintain its leadership in robotics and artificial intelligence will only serve to heighten competition as domestic companies try to outdo foreign competitors through more investment in innovative R&D, government aid, and partnerships with hospitals.
 

Surgical Robots Market Companies

Prominent players operating in the surgical robots industry include:

• ACCURAY
• ASENSUS SURGICAL (KARL STORZ)
• CASCINATION
• CMR SURGICAL
• Distalmotion
• ELMED MEDICAL SYSTEMS
• GLOBUS MEDICAL
• INTUITIVE
• Medtronic
• meerecompany
• RENISHAW
• Smith & Nephew
• Stryker
• THINK SURGICAL
• ZIMMER BIOMET

• Intuitive Surgical’s da Vinci system is a leader in robotic-assisted surgery, providing exceptional precision, 3D-HD visualization, and AI-driven features, which have made it the most widely used surgical robot in the world.
   
• Medtronic’s Hugo RAS system combines a modular design with cloud-based analytics and cost-effectiveness, enhancing access to robotic surgery while incorporating advanced AI assistance to improve patient outcomes.
   

Surgical Robots Industry News

• In January 2024, Intuitive Surgical announced that they have submitted the da Vinci 5 multiport surgical robot for FDA 510(k) clearance. The da Vinci 5 robot will supplement Integrated's existing multiport da Vinci robotic surgical system portfolio that offers multiport X and Xi systems and single port SP. This development is expected to strengthen the company’s competitive strategy.
   
• In February 2024 CMR Surgical introduced vLimeLite, a novel technology that captures ICG (Indocyanine green) imaging as a new component of the Versius Plus system. These features represents an important addition to the existing system. This development expands the market share of CMR Surgical by providing advanced surgical instruments and techniques which result in better surgical results and increased dominance over other surgical robotics competitors.
   
• In December 2021, Accuray Incorporated was granted permission by the Japanese Ministry of Health, Labor, and Welfare (Shonin) to advertise the CyberKnife Robotic Radiosurgery System in Japan for the purpose of treating patients with trigeminal neuralgia (TN) . With the Shonin approval, more patients suffering from TN will be able to receive this high precision radiosurgery therapy which is usually done in one outpatient procedure.
   

The surgical robots market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Component

• Robot systems
• Instruments and accessories

Market, By Application

• Orthopedic surgery
• Neurosurgery
• General surgery
• Gynecology surgery
• Urologic surgery
• Other applications

Market, By End use

• Hospitals
• Ambulatory surgical centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Spain
  • Belgium
  • Sweden
  • Switzerland
  • Netherlands
  • Czech Republic
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Taiwan
  • Singapore
  • Indonesia
  • Thailand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Chile
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Qatar
  • Rest of Middle East and Africa